T1	AdverseReaction 353 367	hepatotoxicity
T2	Factor 343 346	can
T3	AdverseReaction 131 139	diarrhea
T4	AdverseReaction 141 147	nausea
T5	AdverseReaction 149 157	vomiting
T6	AdverseReaction 161 175	abdominal pain
T7	AdverseReaction 505 530	Interstitial Lung Disease
T8	AdverseReaction 532 535	ILD
T9	AdverseReaction 537 548	Pneumonitis
T10	AdverseReaction 742 767	QTc interval prolongation
T11	Factor 732 735	can
T12	AdverseReaction 1102 1115	hyperglycemia
T13	Factor 1092 1095	can
T14	AdverseReaction 1398 1409	bradycardia
T15	Factor 1388 1391	can
T16	AdverseReaction 1562 1582	Elevations of lipase
T17	AdverseReaction 1562 1575;1590 1597	Elevations of amylase
T18	AdverseReaction 1602 1614	pancreatitis
T19	Factor 1615 1618	can
T20	AdverseReaction 1790 1800	fetal harm
T21	Factor 1780 1783	may
T22	AdverseReaction 1975 1983	Diarrhea
T23	AdverseReaction 1985 1991	nausea
T24	AdverseReaction 1993 2001	vomiting
T25	AdverseReaction 2006 2020	abdominal pain
T26	AdverseReaction 2153 2161	diarrhea
T27	AdverseReaction 2163 2169	nausea
T28	AdverseReaction 2171 2179	vomiting
T29	AdverseReaction 2184 2198	abdominal pain
T30	Severity 2063 2069	severe
T31	AdverseReaction 2605 2619	hepatotoxicity
T32	AdverseReaction 2663 2701	Elevations in alanine aminotransferase
T33	Severity 2721 2754	5 times the upper limit of normal
T34	AdverseReaction 2866 2888	elevated transaminases
T35	AdverseReaction 2894 2902	jaundice
T36	AdverseReaction 2915 2932	elevations in ALT
T37	Severity 2946 2961	3 times the ULN
T38	AdverseReaction 3662 3665	ILD
T40	AdverseReaction 3666 3677	pneumonitis
T41	AdverseReaction 3656 3661	fatal
T42	Factor 3678 3681	can
T43	Severity 3627 3633	Severe
T44	Severity 3635 3651	life-threatening
T45	AdverseReaction 3734 3745	pneumonitis
T46	AdverseReaction 3822 3825	ILD
T47	AdverseReaction 3826 3837	pneumonitis
T48	Severity 3809 3816	Grade 3
T49	Severity 3809 3814;3820 3821	Grade 4
T50	AdverseReaction 3874 3879	fatal
T51	AdverseReaction 3880 3883	ILD
T52	AdverseReaction 3884 3895	pneumonitis
T53	AdverseReaction 4009 4012	ILD
T54	AdverseReaction 4013 4024	pneumonitis
T55	AdverseReaction 4362 4387	QTc interval prolongation
T56	AdverseReaction 4429 4457	ventricular tachyarrhythmias
T57	Factor 4420 4424	risk
T58	AdverseReaction 4465 4483	Torsade de pointes
T59	AdverseReaction 4488 4500	sudden death
T60	AdverseReaction 4613 4634	QTc interval increase
T61	Severity 4662 4669	60 msec
T62	AdverseReaction 4833 4858	QTc greater than 500 msec
T64	AdverseReaction 4885 4911	increase from baseline QTc
T65	Severity 4925 4932	60 msec
T66	AdverseReaction 5015 5044	increases in the QTc interval
T67	Factor 4961 4970	suggested
T68	AdverseReaction 5982 5995	Hyperglycemia
T69	Factor 5996 5999	can
T70	AdverseReaction 6065 6078	hyperglycemia
T71	Severity 6055 6062	Grade 3
T72	Severity 6055 6060;6063 6064	Grade 4
T73	Severity 6055 6064	Grade 3-4
T74	AdverseReaction 6200 6213	hyperglycemia
T75	Factor 6176 6180	risk
T76	Severity 6190 6199	Grade 3-4
T77	Severity 6190 6197	Grade 3
T78	Severity 6190 6195;6198 6199	Grade 4
T79	AdverseReaction 6912 6923	Bradycardia
T80	Factor 6924 6927	can
T81	AdverseReaction 6977 6994	sinus bradycardia
T82	AdverseReaction 7009 7052	heart rate of less than 50 beats per minute
T84	AdverseReaction 7104 7115	Bradycardia
T85	AdverseReaction 8326 8338	Pancreatitis
T86	AdverseReaction 8354 8362	fatality
T87	AdverseReaction 8464 8484	elevations of lipase
T88	AdverseReaction 8464 8477;8492 8499	elevations of amylase
T89	Severity 8454 8463	Grade 3-4
T90	Severity 8454 8461	Grade 3
T91	Severity 8454 8459;8462 8463	Grade 4
T92	AdverseReaction 8970 8980	fetal harm
T93	Factor 8960 8963	may
T94	AdverseReaction 9193 9224	increases in skeletal anomalies
T95	Animal 9228 9232	rats
T96	Animal 9237 9244	rabbits
T63	AdverseReaction 2966 2981;2995 3010	total bilirubin 2 times the ULN
T97	AdverseReaction 318 332	Hepatotoxicity
T98	AdverseReaction 697 721	QT Interval Prolongation
T99	AdverseReaction 1068 1081	Hyperglycemia
T100	AdverseReaction 1366 1377	Bradycardia
T101	AdverseReaction 1547 1559	Pancreatitis
T102	AdverseReaction 1749 1769	Embryofetal Toxicity
E1	AdverseReaction:T1 Hypothetical:E2
E2	Factor:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10 Hypothetical:E11
E11	Factor:T11
E12	AdverseReaction:T12 Hypothetical:E13
E13	Factor:T13
E14	AdverseReaction:T14 Hypothetical:E15
E15	Factor:T15
E16	AdverseReaction:T16 Hypothetical:E19
E17	AdverseReaction:T17 Hypothetical:E19
E18	AdverseReaction:T18 Hypothetical:E19
E19	Factor:T19
E20	AdverseReaction:T20 Hypothetical:E21
E21	Factor:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T22 Effect:E34
E31	AdverseReaction:T23 Effect:E34
E32	AdverseReaction:T24 Effect:E34
E33	AdverseReaction:T25 Effect:E34
E34	Severity:T30
E35	AdverseReaction:T31
E36	AdverseReaction:T32 Effect:E37
E37	Severity:T33
E38	AdverseReaction:T34
E39	AdverseReaction:T35
E40	AdverseReaction:T36 Effect:E41
E41	Severity:T37
E42	AdverseReaction:T38 Effect:E47 Effect2:E48 Hypothetical:E46
E44	AdverseReaction:T40 Effect:E47 Effect2:E48 Hypothetical:E46
E45	AdverseReaction:T41
E46	Factor:T42
E47	Severity:T43
E48	Severity:T44
E49	AdverseReaction:T38 Hypothetical:E46
E50	AdverseReaction:T40 Hypothetical:E46
E51	AdverseReaction:T45
E52	AdverseReaction:T46 Effect2:E54 Effect:E55
E53	AdverseReaction:T47 Effect:E55 Effect2:E54
E54	Severity:T48
E55	Severity:T49
E56	AdverseReaction:T50
E57	AdverseReaction:T51
E58	AdverseReaction:T52
E59	AdverseReaction:T53
E60	AdverseReaction:T54
E61	AdverseReaction:T55
E62	AdverseReaction:T56 Hypothetical:E63
E63	Factor:T57
E64	AdverseReaction:T58 Hypothetical:E63
E65	AdverseReaction:T59 Hypothetical:E63
E66	AdverseReaction:T60 Effect:E67
E67	Severity:T61
E68	AdverseReaction:T62
E70	AdverseReaction:T64 Effect:E71
E71	Severity:T65
E72	AdverseReaction:T66 Hypothetical:E73
E73	Factor:T67
E74	AdverseReaction:T68 Hypothetical:E75
E75	Factor:T69
E76	AdverseReaction:T70 Effect:E77 Effect2:E79 Effect3:E78
E77	Severity:T71
E78	Severity:T72
E79	Severity:T73
E80	AdverseReaction:T74 Effect:E82 Effect2:E83 Effect3:E84 Hypothetical:E81
E81	Factor:T75
E82	Severity:T76
E83	Severity:T77
E84	Severity:T78
E85	AdverseReaction:T79 Hypothetical:E86
E86	Factor:T80
E87	AdverseReaction:T81
E88	AdverseReaction:T82
E90	AdverseReaction:T84
E91	AdverseReaction:T85
E92	AdverseReaction:T86
E93	AdverseReaction:T87 Effect:E95 Effect2:E96 Effect3:E97
E94	AdverseReaction:T88 Effect:E96 Effect2:E95 Effect3:E97
E95	Severity:T89
E96	Severity:T90
E97	Severity:T91
E98	AdverseReaction:T92 Hypothetical:E99
E99	Factor:T93
E100	AdverseReaction:T94 Hypothetical:E101 Hypothetical2:E102
E101	Animal:T95
E102	Animal:T96
E69	AdverseReaction:T63
E103	AdverseReaction:T97
E104	AdverseReaction:T98
E105	AdverseReaction:T99
E106	AdverseReaction:T100
E107	AdverseReaction:T101
E108	AdverseReaction:T102
A1	CUI E1 C0235378
A2	UMLS-Preferred-Name E1 Hepatotoxicity
A3	MEDDRA-PT E1 Hepatotoxicity
A4	MEDDRA-PT-ID E1 10019851
A5	CUI E3 C0011991
A6	UMLS-Preferred-Name E3 Diarrhea
A7	MEDDRA-PT E3 Diarrhoea
A8	MEDDRA-PT-ID E3 10012735
A9	LLT E3 Diarrhea
A10	LLT-ID E3 10012727
A11	CUI E4 C0027497
A12	UMLS-Preferred-Name E4 Nausea
A13	MEDDRA-PT E4 Nausea
A14	MEDDRA-PT-ID E4 10028813
A15	CUI E5 C0042963
A16	UMLS-Preferred-Name E5 Vomiting
A17	MEDDRA-PT E5 Vomiting
A18	MEDDRA-PT-ID E5 10047700
A19	CUI E6 C0000737
A20	UMLS-Preferred-Name E6 Abdominal Pain
A21	MEDDRA-PT E6 Abdominal pain
A22	MEDDRA-PT-ID E6 10000081
A23	CUI E7 C0206062
A24	UMLS-Preferred-Name E7 Lung Diseases, Interstitial
A25	MEDDRA-PT E7 Interstitial lung disease
A26	MEDDRA-PT-ID E7 10022611
A27	CUI E8 C0206062
A28	UMLS-Preferred-Name E8 Lung Diseases, Interstitial
A29	MEDDRA-PT E8 Interstitial lung disease
A30	MEDDRA-PT-ID E8 10022611
A31	CUI E9 C3714636
A32	UMLS-Preferred-Name E9 Pneumonitis
A33	MEDDRA-PT E9 Pneumonitis
A34	MEDDRA-PT-ID E9 10035742
A35	CUI E10 C0855333
A36	UMLS-Preferred-Name E10 Electrocardiogram QT corrected interval prolonged
A37	MEDDRA-PT E10 Electrocardiogram QT prolonged
A38	MEDDRA-PT-ID E10 10014387
A39	LLT E10 Electrocardiogram QTc interval prolonged
A40	LLT-ID E10 10053698
A41	CUI E12 C0020456
A42	UMLS-Preferred-Name E12 Hyperglycemia
A43	MEDDRA-PT E12 Hyperglycaemia
A44	MEDDRA-PT-ID E12 10020635
A45	LLT E12 Hyperglycemia
A46	LLT-ID E12 10020639
A47	CUI E14 C0428977
A48	UMLS-Preferred-Name E14 Bradycardia
A49	MEDDRA-PT E14 Bradycardia
A50	MEDDRA-PT-ID E14 10006093
A51	CUI E16 C1963823
A52	UMLS-Preferred-Name E16 Hyperlipasaemia
A53	MEDDRA-PT E16 Lipase increased
A54	MEDDRA-PT-ID E16 10024574
A55	CUI E17 C0151479
A56	UMLS-Preferred-Name E17 Amylase increased
A57	MEDDRA-PT E17 Amylase increased
A58	MEDDRA-PT-ID E17 10002016
A59	CUI E18 C0030305
A60	UMLS-Preferred-Name E18 Pancreatitis
A61	MEDDRA-PT E18 Pancreatitis
A62	MEDDRA-PT-ID E18 10033645
A63	CUI E20 C0854268
A64	UMLS-Preferred-Name E20 Foetal damage
A65	MEDDRA-PT E20 Foetal damage
A66	MEDDRA-PT-ID E20 10016852
A67	LLT E20 Fetal damage
A68	LLT-ID E20 10054743
A69	CUI E22 C0011991
A70	UMLS-Preferred-Name E22 Diarrhea
A71	MEDDRA-PT E22 Diarrhoea
A72	MEDDRA-PT-ID E22 10012735
A73	LLT E22 Diarrhea
A74	LLT-ID E22 10012727
A75	CUI E23 C0027497
A76	UMLS-Preferred-Name E23 Nausea
A77	MEDDRA-PT E23 Nausea
A78	MEDDRA-PT-ID E23 10028813
A79	CUI E24 C0042963
A80	UMLS-Preferred-Name E24 Vomiting
A81	MEDDRA-PT E24 Vomiting
A82	MEDDRA-PT-ID E24 10047700
A83	CUI E25 C0000737
A84	UMLS-Preferred-Name E25 Abdominal Pain
A85	MEDDRA-PT E25 Abdominal pain
A86	MEDDRA-PT-ID E25 10000081
A87	CUI E26 C0011991
A88	UMLS-Preferred-Name E26 Diarrhea
A89	MEDDRA-PT E26 Diarrhoea
A90	MEDDRA-PT-ID E26 10012735
A91	LLT E26 Diarrhea
A92	LLT-ID E26 10012727
A93	CUI E27 C0027497
A94	UMLS-Preferred-Name E27 Nausea
A95	MEDDRA-PT E27 Nausea
A96	MEDDRA-PT-ID E27 10028813
A97	CUI E28 C0042963
A98	UMLS-Preferred-Name E28 Vomiting
A99	MEDDRA-PT E28 Vomiting
A100	MEDDRA-PT-ID E28 10047700
A101	CUI E29 C0000737
A102	UMLS-Preferred-Name E29 Abdominal Pain
A103	MEDDRA-PT E29 Abdominal pain
A104	MEDDRA-PT-ID E29 10000081
A105	CUI E35 C0235378
A106	UMLS-Preferred-Name E35 Hepatotoxicity
A107	MEDDRA-PT E35 Hepatotoxicity
A108	MEDDRA-PT-ID E35 10019851
A109	CUI E36 C0151905
A110	UMLS-Preferred-Name E36 Alanine aminotransferase increased
A111	MEDDRA-PT E36 Alanine aminotransferase increased
A112	MEDDRA-PT-ID E36 10001551
A113	CUI E38 C0438717
A114	UMLS-Preferred-Name E38 Transaminases increased
A115	MEDDRA-PT E38 Transaminases increased
A116	MEDDRA-PT-ID E38 10054889
A117	CUI E39 C0022346
A118	UMLS-Preferred-Name E39 Icterus
A119	MEDDRA-PT E39 Jaundice
A120	MEDDRA-PT-ID E39 10023126
A121	CUI E40 C0151905
A122	UMLS-Preferred-Name E40 Alanine aminotransferase increased
A123	MEDDRA-PT E40 Alanine aminotransferase increased
A124	MEDDRA-PT-ID E40 10001551
A125	LLT E40 ALT increased
A126	LLT-ID E40 10001845
A127	CUI E42 C0206062
A128	UMLS-Preferred-Name E42 Lung Diseases, Interstitial
A129	MEDDRA-PT E42 Interstitial lung disease
A130	MEDDRA-PT-ID E42 10022611
A131	CUI E44 C3714636
A132	UMLS-Preferred-Name E44 Pneumonitis
A133	MEDDRA-PT E44 Pneumonitis
A134	MEDDRA-PT-ID E44 10035742
A135	CUI E45 C1306577
A136	UMLS-Preferred-Name E45 Death (finding)
A137	MEDDRA-PT E45 Death
A138	MEDDRA-PT-ID E45 10011906
A139	CUI E51 C3714636
A140	UMLS-Preferred-Name E51 Pneumonitis
A141	MEDDRA-PT E51 Pneumonitis
A142	MEDDRA-PT-ID E51 10035742
A143	CUI E52 C0206062
A144	UMLS-Preferred-Name E52 Lung Diseases, Interstitial
A145	MEDDRA-PT E52 Interstitial lung disease
A146	MEDDRA-PT-ID E52 10022611
A147	CUI E53 C3714636
A148	UMLS-Preferred-Name E53 Pneumonitis
A149	MEDDRA-PT E53 Pneumonitis
A150	MEDDRA-PT-ID E53 10035742
A151	CUI E56 C1306577
A152	UMLS-Preferred-Name E56 Death (finding)
A153	MEDDRA-PT E56 Death
A154	MEDDRA-PT-ID E56 10011906
A155	CUI E57 C0206062
A156	UMLS-Preferred-Name E57 Lung Diseases, Interstitial
A157	MEDDRA-PT E57 Interstitial lung disease
A158	MEDDRA-PT-ID E57 10022611
A159	CUI E58 C3714636
A160	UMLS-Preferred-Name E58 Pneumonitis
A161	MEDDRA-PT E58 Pneumonitis
A162	MEDDRA-PT-ID E58 10035742
A163	CUI E59 C0206062
A164	UMLS-Preferred-Name E59 Lung Diseases, Interstitial
A165	MEDDRA-PT E59 Interstitial lung disease
A166	MEDDRA-PT-ID E59 10022611
A167	CUI E60 C3714636
A168	UMLS-Preferred-Name E60 Pneumonitis
A169	MEDDRA-PT E60 Pneumonitis
A170	MEDDRA-PT-ID E60 10035742
A171	CUI E61 C0855333
A172	UMLS-Preferred-Name E61 Electrocardiogram QT corrected interval prolonged
A173	MEDDRA-PT E61 Electrocardiogram QT prolonged
A174	MEDDRA-PT-ID E61 10014387
A175	LLT E61 Electrocardiogram QTc interval prolonged
A176	LLT-ID E61 10053698
A177	CUI E62 C0042514
A178	UMLS-Preferred-Name E62 Tachycardia, Ventricular
A179	MEDDRA-PT E62 Ventricular tachyarrhythmia
A180	MEDDRA-PT-ID E62 10065341
A181	CUI E64 C0040479
A182	UMLS-Preferred-Name E64 Torsades de Pointes
A183	MEDDRA-PT E64 Torsade de pointes
A184	MEDDRA-PT-ID E64 10044066
A185	CUI E65 C0011071
A186	UMLS-Preferred-Name E65 Sudden death
A187	MEDDRA-PT E65 Sudden death
A188	MEDDRA-PT-ID E65 10042434
A189	CUI E66 C0855333
A190	UMLS-Preferred-Name E66 Electrocardiogram QT corrected interval prolonged
A191	MEDDRA-PT E66 Electrocardiogram QT prolonged
A192	MEDDRA-PT-ID E66 10014387
A193	LLT E66 Electrocardiogram QTc interval prolonged
A194	LLT-ID E66 10053698
A195	CUI E68 C0855333
A196	UMLS-Preferred-Name E68 Electrocardiogram QT corrected interval prolonged
A197	MEDDRA-PT E68 Electrocardiogram QT prolonged
A198	MEDDRA-PT-ID E68 10014387
A199	LLT E68 Electrocardiogram QTc interval prolonged
A200	LLT-ID E68 10053698
A201	CUI E70 C0855333
A202	UMLS-Preferred-Name E70 Electrocardiogram QT corrected interval prolonged
A203	MEDDRA-PT E70 Electrocardiogram QT prolonged
A204	MEDDRA-PT-ID E70 10014387
A205	LLT E70 Electrocardiogram QTc interval prolonged
A206	LLT-ID E70 10053698
A207	CUI E72 C0855333
A208	UMLS-Preferred-Name E72 Electrocardiogram QT corrected interval prolonged
A209	MEDDRA-PT E72 Electrocardiogram QT prolonged
A210	MEDDRA-PT-ID E72 10014387
A211	LLT E72 Electrocardiogram QTc interval prolonged
A212	LLT-ID E72 10053698
A213	CUI E74 C0020456
A214	UMLS-Preferred-Name E74 Hyperglycemia
A215	MEDDRA-PT E74 Hyperglycaemia
A216	MEDDRA-PT-ID E74 10020635
A217	LLT E74 Hyperglycemia
A218	LLT-ID E74 10020639
A219	CUI E76 C0020456
A220	UMLS-Preferred-Name E76 Hyperglycemia
A221	MEDDRA-PT E76 Hyperglycaemia
A222	MEDDRA-PT-ID E76 10020635
A223	LLT E76 Hyperglycemia
A224	LLT-ID E76 10020639
A225	CUI E80 C0020456
A226	UMLS-Preferred-Name E80 Hyperglycemia
A227	MEDDRA-PT E80 Hyperglycaemia
A228	MEDDRA-PT-ID E80 10020635
A229	LLT E80 Hyperglycemia
A230	LLT-ID E80 10020639
A231	CUI E85 C0428977
A232	UMLS-Preferred-Name E85 Bradycardia
A233	MEDDRA-PT E85 Bradycardia
A234	MEDDRA-PT-ID E85 10006093
A235	CUI E87 C0085610
A236	UMLS-Preferred-Name E87 Sinus bradycardia
A237	MEDDRA-PT E87 Sinus bradycardia
A238	MEDDRA-PT-ID E87 10040741
A239	CUI E88 C2230138
A240	UMLS-Preferred-Name E88 Pulse slow (finding)
A241	MEDDRA-PT E88 Heart rate decreased
A242	MEDDRA-PT-ID E88 10019301
A243	CUI E90 C0428977
A244	UMLS-Preferred-Name E90 Bradycardia
A245	MEDDRA-PT E90 Bradycardia
A246	MEDDRA-PT-ID E90 10006093
A247	CUI E91 C0030305
A248	UMLS-Preferred-Name E91 Pancreatitis
A249	MEDDRA-PT E91 Pancreatitis
A250	MEDDRA-PT-ID E91 10033645
A251	CUI E92 C1306577
A252	UMLS-Preferred-Name E92 Death (finding)
A253	MEDDRA-PT E92 Death
A254	MEDDRA-PT-ID E92 10011906
A255	CUI E93 C1963823
A256	UMLS-Preferred-Name E93 Hyperlipasaemia
A257	MEDDRA-PT E93 Lipase increased
A258	MEDDRA-PT-ID E93 10024574
A259	CUI E94 C0151479
A260	UMLS-Preferred-Name E94 Amylase increased
A261	MEDDRA-PT E94 Amylase increased
A262	MEDDRA-PT-ID E94 10002016
A263	CUI E98 C0854268
A264	UMLS-Preferred-Name E98 Foetal damage
A265	MEDDRA-PT E98 Foetal damage
A266	MEDDRA-PT-ID E98 10016852
A267	LLT E98 Fetal damage
A268	LLT-ID E98 10054743
A269	CUI E100 C0151491
A270	UMLS-Preferred-Name E100 Congenital musculoskeletal anomalies
A271	MEDDRA-PT E100 Congenital musculoskeletal anomaly
A272	MEDDRA-PT-ID E100 10062344
A273	LLT E100 Other congenital musculoskeletal anomalies
A274	LLT-ID E100 10031851
A275	CUI E69 C0741494
A276	UMLS-Preferred-Name E69 Elevated total bilirubin
A277	MEDDRA-PT E69 Blood bilirubin increased
A278	MEDDRA-PT-ID E69 10005364
A279	LLT E69 Bilirubin total increased
A280	LLT-ID E69 10056806
A281	CUI E103 C0235378
A282	UMLS-Preferred-Name E103 Hepatotoxicity
A283	MEDDRA-PT E103 Hepatotoxicity
A284	MEDDRA-PT-ID E103 10019851
A285	CUI E104 C0151878
A286	UMLS-Preferred-Name E104 Prolonged QT interval
A287	MEDDRA-PT E104 Electrocardiogram QT prolonged
A288	MEDDRA-PT-ID E104 10014387
A289	LLT E104 QT interval prolonged
A290	LLT-ID E104 10037703
A291	CUI E105 C0020456
A292	UMLS-Preferred-Name E105 Hyperglycemia
A293	MEDDRA-PT E105 Hyperglycaemia
A294	MEDDRA-PT-ID E105 10020635
A295	LLT E105 Hyperglycemia
A296	LLT-ID E105 10020639
A297	CUI E106 C0428977
A298	UMLS-Preferred-Name E106 Bradycardia
A299	MEDDRA-PT E106 Bradycardia
A300	MEDDRA-PT-ID E106 10006093
A301	CUI E107 C0030305
A302	UMLS-Preferred-Name E107 Pancreatitis
A303	MEDDRA-PT E107 Pancreatitis
A304	MEDDRA-PT-ID E107 10033645
A305	CUI E108 C0270009
A306	UMLS-Preferred-Name E108 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A307	MEDDRA-PT E108 Maternal drugs affecting foetus
A308	MEDDRA-PT-ID E108 10026923
A309	LLT E108 Drug toxicity NEC affecting foetus
A310	LLT-ID E108 10013750
